Reviva Pharmaceuticals Holdings, Inc. (RVPH)

NASDAQ: RVPH · IEX Real-Time Price · USD

1.080

-0.110 (-9.24%)

At close: Jul 2, 2024, 4:00 PM

1.060

-0.020 (-1.85%)

After-hours: Jul 2, 2024, 7:49 PM EDT

RVPH Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	32	117	87	40	45	86
Market Cap Growth	-0.09%	34.26%	115.01%	-9.83%	-48.16%	-
Enterprise Value	21	93	68	11	36	90
PE Ratio	-	-2.97	-3.07	-4.74	-11.84	-102.09
PB Ratio	-63.62	20.40	10.35	1.41	8.20	-12.69
P/FCF Ratio	-2.67	-4.12	-4.58	-3.79	-11.02	-395.77
P/OCF Ratio	-2.67	-4.12	-4.58	-3.79	-11.02	-395.77
EV/EBITDA Ratio	-1.85	-2.38	-2.42	-1.26	-15.48	-239.93
EV/EBIT Ratio	-1.85	-2.38	-2.42	-1.26	-15.48	-239.52
EV/FCF Ratio	-2.30	-3.29	-3.61	-1.00	-8.87	-413.00
Debt / Equity Ratio	-0.25	-	-	-	-	-0.55
Debt / EBITDA Ratio	-0.01	-	-	-	-	-10.01
Debt / FCF Ratio	-0.01	-	-	-	-	-17.24
Quick Ratio	0.83	1.36	1.86	12.66	6.57	-
Interest Coverage	-23121.06	-	-	-	-1.60	-0.80
Return on Equity (ROE)	6350.30%	-3410.00%	-170.80%	-34.10%	562.30%	-
Return on Assets (ROA)	-294.70%	-291.70%	-127.20%	-31.40%	-86.30%	-
Return on Capital (ROIC)	4013.56%	-690.78%	-336.29%	-35.22%	-44.54%	12.37%
Earnings Yield	-124.50%	-33.66%	-32.53%	-21.09%	-8.44%	-0.98%
FCF Yield	-99.68%	-24.28%	-21.82%	-26.40%	-9.07%	-0.25%
Buyback Yield / Dilution	-36.89%	-21.94%	-31.95%	-383.10%	-10.60%	-
Total Shareholder Return	-36.89%	-21.94%	-31.95%	-383.10%	-10.60%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).